Emerging Trends in Minimally Invasive Glaucoma Surgery (MIGS) Devices MIGS Devices Market | Page 4

Key Benefits
• The MIGS stents generated the highest revenue in 2016, and is anticipated to do so
throughout the forecast period, registering a CAGR of 27.1% from 2017 to 2023.
• Eye hospitals dominated the market, accounting for maximum share in 2016 and is
expected to witness a CAGR of 26.3% from 2017 to 2023.
• North America dominated the global minimally invasive glaucoma surgery (MIGS)
market, accounting for maximum share in 2016 and is expected to retain the same
trend during 2017 to 2023.
• The MIGS shunts product segment is expected to witness the highest growth rate
during the forecast period.
• Japan accounted for one-fourth share of the Asia-Pacific minimally invasive
glaucoma surgery (MIGS) devices market in 2016.